OSX2:F:F-Ossiam Lux - Ossiam US Minimum Variance NR (EUR)

ETF | Others |

Last Closing

USD 304.8

Change

+2.60 (+0.86)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.10 (-0.20%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

+2.94 (+0.50%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

+0.31 (+0.29%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.52 (+0.49%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.89B
0ZC:F Zscaler Inc

-0.46 (-0.24%)

USD 37.92B

ETFs Containing OSX2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.48% 81% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.48% 78% C+ 68% D+
Trailing 12 Months  
Capital Gain 24.74% 76% C+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.74% 73% C 64% D
Trailing 5 Years  
Capital Gain 45.32% 72% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.32% 72% C 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.85% 64% D 63% D
Dividend Return 7.85% 61% D- 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.99% 67% D+ 89% A-
Risk Adjusted Return 78.57% 83% B 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike